Recent BCYC News
- Bicycle Therapeutics to Participate in Upcoming Investor Conferences • Business Wire • 08/21/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/06/2024 09:00:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 11:40:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:05:18 AM
- Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results • Business Wire • 08/06/2024 11:05:00 AM
- Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/01/2024 08:05:00 PM
- Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024 • Business Wire • 07/22/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 08:50:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 10:57:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 10:55:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 10:55:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 10:55:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 10:55:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 10:55:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 10:55:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:18:05 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 06/18/2024 08:14:42 PM
- Bicycle Therapeutics to Participate in Upcoming Investor Conferences • Business Wire • 06/03/2024 11:00:00 AM
- Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting • Business Wire • 05/23/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:26:06 PM
- Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing • Business Wire • 05/23/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 08:01:29 PM
- Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results • Business Wire • 05/02/2024 11:00:00 AM
- Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting • Business Wire • 04/24/2024 02:05:00 PM
- Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference • Business Wire • 04/02/2024 11:00:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM